Authors’ Reply – Comments: Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
Main Authors: | Luis Eduardo Miani Gomes, Francesca Aparecida Ramos da Silva, Lívia Bitencourt Pascoal, Renato Lazarin Ricci, Guilherme Nogueira, Michel Gardere Camargo, Maria de Lourdes Setsuko Ayrizono, João José Fagundes, Raquel Franco Leal |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculdade de Medicina / USP
|
Series: | Clinics |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322019000100405&lng=en&tlng=en |
Similar Items
-
Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn’s Disease
by: Luis Eduardo Miani Gomes, et al.
Published: (2019-04-01) -
AVALIAÇÃO DOS NÍVEIS SÉRICOS E DETECÇÃO DE ANTICORPOS ANTI‐INFLIXIMABE EM PACIENTES COM DOENÇA DE CROHN
by: Luis Eduardo Miani, et al.
Published: (2017-10-01) -
Serum levels of infliximab in Brazilian patients with Crohn's disease: what are the reasons for differences from previous studies?
by: Fabio Vieira Teixeira, et al. -
Infliximab therapy for Crohn’s disease in the presence of chronic hepatitis C infection - Reply
by: M. Galeazzi
Published: (2003-06-01) -
Infliximab in Crohn's disease Infliximab en la enfermedad de Crohn
by: L. Rodrigo Sáez
Published: (2004-06-01)